Intravenous dextrose during outpatient rehydration in pediatric gastroenteritis

Jason A Levy1, Richard G Bachur

  • 1Division of Emergency Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA. jason.levy@childrens.harvard.edu

Insights

Higher IV dextrose doses in children with acute gastroenteritis and dehydration are linked to fewer return visits requiring admission. This finding suggests optimal dextrose administration may improve outcomes and reduce hospital readmissions.

Area of Science:

  • Pediatric Emergency Medicine
  • Gastroenterology
  • Clinical Nutrition

Background:

  • Acute gastroenteritis (AGE) in children often necessitates intravenous (IV) rehydration in emergency departments (ED).
  • Understanding factors influencing return visits with admission (RVA) is crucial for optimizing pediatric care.

Purpose of the Study:

  • To investigate the association between IV dextrose administration and RVA in children with AGE and dehydration.
  • To identify other clinical, laboratory, and treatment parameters linked to RVA.

Main Methods:

  • A case-control study involving children aged 6 months to 6 years with AGE and dehydration receiving IV rehydration.
  • Cases were defined as patients with RVA within 72 hours; controls had no RVA.
  • Analysis focused on IV dextrose amount and other clinical/treatment factors.

Main Results:

  • Children with RVA received significantly less IV dextrose (399 mg/kg) compared to controls (747 mg/kg).
  • No IV dextrose increased RVA odds by 3.9 times; each 500 mg/kg increase in dextrose reduced RVA likelihood by 1.9 times.
  • Shorter symptom duration (≤1 day) was associated with higher RVA likelihood.

Conclusions:

  • Increased IV dextrose administration is associated with a reduced incidence of return visits requiring admission in pediatric AGE.
  • Dextrose dosage appears to be a significant factor in preventing readmission for dehydrated children with gastroenteritis.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...